New Year brings New PBS listings

The first day of the new year brought with it new hope for Australians fighting one of the most common blood cancers, thanks to a critical new medicine listed on the Pharmaceutical Benefits Scheme (PBS).On 1st January 2021, Darzalex® (daratumumab) was listed for the first time in combination with bortezomib and dexamethasone, as a second-line…

PBS support for Australians living with leukaemia

Patients living with one of Australia’s most common forms of leukaemia are set to benefit from expanded access to a breakthrough medicine through the Pharmaceutical Benefits Scheme (PBS).   From 1 December, access to Venclexta® (venetoclax) will be extended in combination with obinutuzumab for the first-line treatment of patients with chronic lymphocytic leukaemia who have…

Life-saving SMA medicine to be made available to Australian babies

Access to a life-saving and life-changing medicine will soon be expanded for Australian children and infants with Spinal Muscular Atrophy (SMA).   From 1 December, subsidised access to the life-changing medicine Spinraza® (nusinersen) will be expanded on the Pharmaceutical Benefits Scheme (PBS). It will include children and infants genetically diagnosed with the most severe types…

NEW MEDICINES LISTED ON THE PBS

Australians suffering from melanoma and multiple sclerosis have new treatment options, with new and amended PBS listings. 🔸 Tafinlar® (dabrafenib) and Mekinist® (trametinib) will be extended to include subsidy for post-surgery treatment for patients who have Stages IIIB, IIIC and IIID melanoma. 🔸 Gilenya® (fingolimod) will be amended to include a new strength of this medicine for…

Cheaper medicine for over 500,000 patients

Cheaper medicine is avaliable for more than 500,000 patients, with price reductions for common scripts and new medicines added to the Pharmaceutical Benefits Scheme (PBS), the Federal Member for Page Kevin Hogan said. “In some cases this will save over $100,000 per patient,” “Medicines to treat lung cancer, lymphoblastic and acute leukaemia, and nausea associated…

$27 million for new PBS medicines

The Government will invest $27 million to provide affordable access to three new medicines through the Pharmaceutical Benefits Scheme (PBS), helping Australians living with complications following stroke, fighting cancer, and experiencing syphilis in northern, central and southern Australia. The September 1 PBS listings will include amending the current listing for Opdivo® (Nivolumab) for the treatment…